Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
February 13, 2025
A Window into New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current Perspective
Tommaso Guerra, Pietro Iaffaldano
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2021
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
Tommaso Guerra, Luca Bollo, Maria Trojano, et al.
Drugs - Real World Outcomes
|
March 14, 2025
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
Tommaso Guerra, Francesca Caputo, Antonella Bianco, et al.
Clinical Neurology and Neurosurgery
|
August 19, 2024
Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series
Antonella Bianco, Tommaso Guerra, Francesca Caputo, et al.
Medicina (Kaunas, Lithuania)
|
December 31, 2025
Assessment of the RoAD Score as a Predictor of Long-Term Irreversible Ambulatory Disability in Multiple Sclerosis: Evidence from a Real-World Cohort
Tommaso Guerra, Chiara Esposto, Sara Limitone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 7, 2021
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years
Tommaso Guerra, Francesca Caputo, Bianca Orlando, et al.
Journal of Clinical Nursing
|
June 15, 2026
Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study
Francesco Pastore, Barbara Forastefano, Valentina Simonetti, et al.
Clinical Case Reports
|
October 27, 2021
Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-report
Carlo Santoro, Tommaso Guerra, Eustachio D'Errico, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Live Cell-Based Semi-Quantitative Stratification Highlights Titre-Dependent Phenotypic Heterogeneity in MOGAD: A Single-Centre Experience
Donato Regina, Concetta Domenica Gargano, Tommaso Guerra, et al.
Clinical Neurology and Neurosurgery
|
August 21, 2021
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Alessandro Introna, Francesca Caputo, Carlo Santoro, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
February 13, 2025
A Window into New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current Perspective
Tommaso Guerra, Pietro Iaffaldano
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2021
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
Tommaso Guerra, Luca Bollo, Maria Trojano, et al.
Drugs - Real World Outcomes
|
March 14, 2025
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
Tommaso Guerra, Francesca Caputo, Antonella Bianco, et al.
Clinical Neurology and Neurosurgery
|
August 19, 2024
Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series
Antonella Bianco, Tommaso Guerra, Francesca Caputo, et al.
Medicina (Kaunas, Lithuania)
|
December 31, 2025
Assessment of the RoAD Score as a Predictor of Long-Term Irreversible Ambulatory Disability in Multiple Sclerosis: Evidence from a Real-World Cohort
Tommaso Guerra, Chiara Esposto, Sara Limitone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 7, 2021
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years
Tommaso Guerra, Francesca Caputo, Bianca Orlando, et al.
Journal of Clinical Nursing
|
June 15, 2026
Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study
Francesco Pastore, Barbara Forastefano, Valentina Simonetti, et al.
Clinical Case Reports
|
October 27, 2021
Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-report
Carlo Santoro, Tommaso Guerra, Eustachio D'Errico, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Live Cell-Based Semi-Quantitative Stratification Highlights Titre-Dependent Phenotypic Heterogeneity in MOGAD: A Single-Centre Experience
Donato Regina, Concetta Domenica Gargano, Tommaso Guerra, et al.
Clinical Neurology and Neurosurgery
|
August 21, 2021
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Alessandro Introna, Francesca Caputo, Carlo Santoro, et al.
Page
of 3